Purchase Order 75N98026P00555

<p>The NIH Clinical Center awarded a purchase order to Terumo BCT Inc. valued at $63,000 on April 27, 2018, for firm fixed-price procurement of medical equipment and related products. Performance is located in Bethesda, Maryland. The order is not set-aside. Ultimate completion is scheduled for June 4, 2018.</p>

The Department of Health and Human Services National Institutes of Health Clinical Center has awarded a $173,189.14 firm-fixed-price purchase order to Terumo BCT Inc., a manufacturer of medical devices and provider of blood and cell technology services. The purpose of the contract is to acquire two Optia Automated Blood Cell Separators to replace the current Spectra Optia systems that have exceeded their recommended service life. This contract was not set aside for any particular business size...

The National Institutes of Health Clinical Center awarded a purchase order valued at $77,280 to Terumo BCT Inc. (doing business as Caridianbct Inc.) on August 6, 2019. This firm fixed-price contract was issued to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a), with an ultimate completion date of August 23, 2021. The contract was performed at the NIH Clinical Center's Bethesda, Maryland location and carried no small...

Terumo BCT, Inc. was awarded a firm fixed price purchase order in the amount of thirty-six thousand five hundred seventy dollars ($36,570) by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to provide thirty Spectra Optia Apheresis IDL disposables kits. The solicitation requested the specific brand name kits containing six disposables each to support the National Institute on Aging Clinical Research Core's Institutional Review...

The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $13,324 purchase order to Terumo BCT Inc., doing business as CaridianBCT, for preventative maintenance service of a Spectra Optia apheresis system located in Lakewood, Colorado. As the prime contractor, Terumo BCT will provide maintenance and support services for the blood collection device under a firm fixed price contract running from November 1, 2023 through October 31, 2024. The...

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a firm fixed price purchase order to Terumo BCT Inc., a manufacturer of medical devices and provider of services related to blood and cell technologies. The $141,531.54 award provides for preventative maintenance of three Elutra and seven Cobe 2991 cell processing/apheresis devices at the Clinical Center, which are used in the manufacture of cell-based therapies for patients enrolled in...

This federal contract award to Terumo BCT, Inc., a foreign-owned, for-profit manufacturer of medical devices and blood and cell technology services, is for the procurement of 2 Spectra Optia Apheresis Systems, catalog number 61000. The contract, valued at $183,580.50, is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center, a civilian federal agency. The contract has an ultimate completion date of June 30, 2025 and was awarded on May 29, 2025....

Terumo BCT, Inc., doing business as CaridianBCT, has been awarded a firm fixed-price purchase order valued at twenty-five thousand two hundred ninety-eight dollars and twenty-six cents ($25,298.26) by the Department of Health and Human Services' National Institutes of Health Clinical Center. The contract term runs from October 31, 2023 through December 15, 2023. Performance will take place in Lakewood, Colorado. As the prime contractor, Terumo BCT will provide unspecified products or services to...

This federal contract award, valued at $44,963.38, was issued by the National Institutes of Health (NIH) Clinical Center to Terumo BCT Inc., a foreign-owned, for-profit manufacturer of medical devices and blood and cell technology services. The contract is for the procurement of Optia apheresis machines and related preventative maintenance services, with a period of performance from June 27, 2025 to June 26, 2026, and two optional one-year extension periods. This is a firm-fixed-price purchase...

Terumo BCT Inc. was awarded a firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health Clinical Center to provide preventative maintenance services. The $47,177.18 contract has a period of performance through May 9, 2025 at the agency location in Bethesda, Maryland. As a manufacturer of blood and cell technologies, Terumo BCT will support equipment used in apheresis, cell therapy, and transfusion medicine applications at the Clinical Center....